RCE 1.06% 47.5¢ recce pharmaceuticals ltd

Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection, page-2

  1. 5,288 Posts.
    lightbulb Created with Sketch. 683
    Only read top lines but Yess yes yes lol. Great looking and have been desperately looking forward to

    Highlights:• Broad spectrum antibiotic activity on bacterial Burn Wound infections withvisible infection reduction <24 hours on all patients to date• All infections cleared within 5 days (acute) or 7 days (chronic); clinicians reducing treatment windows per protocol/positive patient indications• Burn wound infections consisted of Gram-positive and Gram-negative bacteria, including multi-drug resistant and ‘biofilm’ categorised forms• Update in-line with reaching clinical trial end-points; patient recruitment ongoing
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
47.5¢
Change
0.005(1.06%)
Mkt cap ! $96.89M
Open High Low Value Volume
47.0¢ 47.5¢ 47.0¢ $134.2K 284.4K

Buyers (Bids)

No. Vol. Price($)
2 60696 47.0¢
 

Sellers (Offers)

Price($) Vol. No.
47.5¢ 13798 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.